| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2023 ( Subtotal = $8,521,340 ) |
| | 2023 | 2023 | MCLEAN HOSPITAL CORPORATION, THE | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R21MH127506 | Discovery of the Rostromedial Tegmental Nucleus in the Human Brain | 000 | 2 | NIH | 1/13/2023 | $246,000 |
| | 2023 | 2023 | MCLEAN HOSPITAL CORPORATION, THE | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | F32MH125634 | Thalamolimbic circuit mechanisms for social threat processing | 000 | 3 | NIH | 12/16/2022 | $72,082 |
| | 2023 | 2023 | MCLEAN HOSPITAL CORPORATION, THE | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01MH119227 | Multimodal Approaches to Neurobiology of Traumatic Dissociation | 000 | 4 | NIH | 1/26/2023 | $764,791 |
| | 2023 | 2023 | MCLEAN HOSPITAL CORPORATION, THE | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01MH121617 | Mobile Measures of Threat Sensitivity for Cross-sectional and Longitudinal Assessment | 000 | 3 | NIH | 12/12/2022 | $699,297 |
| | 2023 | 2023 | MCLEAN HOSPITAL CORPORATION, THE | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01MH121617 | Mobile Measures of Threat Sensitivity for Cross-sectional and Longitudinal Assessment | 001 | 3 | NIH | 1/20/2023 | $77,701 |
| | 2023 | 2023 | MCLEAN HOSPITAL CORPORATION, THE | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | U01NS109463 | Parkinsons Disease Scalable iPSC Autologous Cell Therapy | 001 | 4 | NIH | 1/11/2023 | $1,765,165 |
| | 2023 | 2023 | MCLEAN HOSPITAL CORPORATION, THE | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01MH117012 | Neuroprogression across the Psychosis Spectrum in the Early Course of Illness | 000 | 5 | NIH | 1/16/2023 | $471,064 |
| | 2023 | 2023 | MCLEAN HOSPITAL CORPORATION, THE | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01MH114982 | Molecular Mechanisms and Biomarkers for Disease Progression from Prodrome to Early Psychosis | 000 | 5 | NIH | 11/18/2022 | $381,671 |
| | 2023 | 2023 | MCLEAN HOSPITAL CORPORATION, THE | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01MH111676 | Computational mechanisms of memory disruption in depression | 001 | 5 | NIH | 1/19/2023 | $41,000 |
| | 2023 | 2023 | MCLEAN HOSPITAL CORPORATION, THE | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R21MH131881 | Building normative models of Reinforcement Learning Decision Making Behavior | 000 | 1 | NIH | 11/29/2022 | $246,000 |
| | 2023 | 2023 | MCLEAN HOSPITAL CORPORATION, THE | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01MH111676 | Computational mechanisms of memory disruption in depression | 000 | 5 | NIH | 11/2/2022 | $369,000 |
| | 2023 | 2023 | MCLEAN HOSPITAL CORPORATION, THE | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | RF1AG080636 | ApoE, lipid and immune mechanisms of human neurons and glia | 000 | 1 | NIH | 12/5/2022 | $2,284,296 |
| | 2023 | 2023 | MCLEAN HOSPITAL CORPORATION, THE | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | K00HD112293 | Elucidating interactions among early life adversity, sleep architecture, and immune function | 000 | 3 | NIH | 1/13/2023 | $86,378 |
| | 2023 | 2023 | MCLEAN HOSPITAL CORPORATION, THE | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | K01MH129828 | Multimodal characterization of affective visual processing in the early aftermath of trauma | 000 | 1 | NIH | 12/7/2022 | $179,707 |
| | 2023 | 2023 | MCLEAN HOSPITAL CORPORATION, THE | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01MH126000 | Empirical validation of a cerebellar-cortical hallucination circuit | 000 | 2 | NIH | 11/7/2022 | $604,336 |
| | 2023 | 2023 | MCLEAN HOSPITAL CORPORATION, THE | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01MH126000 | Empirical validation of a cerebellar-cortical hallucination circuit | 001 | 2 | NIH | 1/19/2023 | $67,148 |
| | 2023 | 2023 | MCLEAN HOSPITAL CORPORATION, THE | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | K23MH126193 | Interpretation Bias as a Mechanism of Treatment Response in OCD | 000 | 2 | NIH | 1/3/2023 | $181,743 |
| | 2023 | 2023 | MCLEAN HOSPITAL CORPORATION, THE | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01MH108665 | Cell Type Specific Genomic and Functional Dissection of Fear-Off Amygdala Pathways | 000 | 7 | NIH | 1/20/2023 | $39,934 |
| | 2023 | 2022 | MCLEAN HOSPITAL CORPORATION, THE | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | U01NS109463 | Parkinsons Disease Scalable iPSC Autologous Cell Therapy | 000 | 3 | NIH | 11/23/2022 | $0 |
| | 2023 | 2022 | MCLEAN HOSPITAL CORPORATION, THE | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01MH116969 | Predicting the onset of depression in at-risk adolescents from endophenotype profiles | 000 | 4 | NIH | 12/1/2022 | $0 |
| | 2023 | 2022 | MCLEAN HOSPITAL CORPORATION, THE | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | P50MH115874 | Silvio O. Conte Center for Stress Peptide Advanced Research, Education, & Dissemination (SPARED) at McLean Hospital | 000 | 4 | NIH | 1/20/2023 | $0 |
| | 2023 | 2022 | MCLEAN HOSPITAL CORPORATION, THE | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | K00HD111352 | Transgenerational Impact of Childhood Maltreatment on Structural/Functional Properties of Visual Cortex | 000 | 3 | NIH | 12/13/2022 | $0 |
| | 2023 | 2021 | MCLEAN HOSPITAL CORPORATION, THE | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | K00DA053527 | Role of the estrous cycle and nucleus accumbens signaling on incubation of oxycodone craving in female rats | 000 | 4 | NIH | 11/13/2022 | -$45,364 |
| | 2023 | 2021 | MCLEAN HOSPITAL CORPORATION, THE | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | K24AA025977 | Mentoring in Patient-Oriented Neuroscience Research | 000 | 5 | NIH | 12/29/2022 | $0 |
| | 2023 | 2021 | MCLEAN HOSPITAL CORPORATION, THE | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01MH111542 | Brain and Behavior Mechanisms of Irritability and Cognitive Flexibility in Children | 000 | 6 | NIH | 12/15/2022 | $0 |
| | 2023 | 2020 | MCLEAN HOSPITAL CORPORATION, THE | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01NS097512 | Mechanisms of Cerebrovascular Reactivity in Health and Disease | 000 | 5 | NIH | 11/21/2022 | $0 |
| | 2023 | 2020 | MCLEAN HOSPITAL CORPORATION, THE | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | F32MH115530 | A Randomized Controlled Trial of Cognitive Control Training for Urgency in a Naturalistic Clinical Setting | 000 | 3 | NIH | 11/23/2022 | -$10,768 |
| | 2023 | 2018 | MCLEAN HOSPITAL CORPORATION, THE | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | K23DA035297 | Behavioral Treatment Development for Co-occurring Opioid Dependence and Anxiety | 000 | 5 | NIH | 10/17/2022 | $159 |
|
| Issue Date FY: 2022 ( Subtotal = $30,119,626 ) (Continued on the next page) |
| | 2022 | 2022 | MCLEAN HOSPITAL CORPORATION, THE | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | P50MH115874 | Silvio O. Conte Center for Stress Peptide Advanced Research, Education, & Dissemination (SPARED) at McLean Hospital | 001 | 4 | NIH | 2/28/2022 | $133,540 |
| | 2022 | 2022 | MCLEAN HOSPITAL CORPORATION, THE | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01MH116969 | Predicting the onset of depression in at-risk adolescents from endophenotype profiles | 001 | 4 | NIH | 5/16/2022 | $59,283 |
| | 2022 | 2022 | MCLEAN HOSPITAL CORPORATION, THE | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01MH116969 | Predicting the onset of depression in at-risk adolescents from endophenotype profiles | 000 | 4 | NIH | 11/1/2021 | $533,544 |
| | 2022 | 2022 | MCLEAN HOSPITAL CORPORATION, THE | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | K01MH118467 | Characterizing the Neurobiology of Pathological Dissociation: Mechanisms of Face Perception and Self Referential Processing | 000 | 4 | NIH | 5/19/2022 | $156,586 |
| | 2022 | 2022 | MCLEAN HOSPITAL CORPORATION, THE | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01MH117012 | Neuroprogression across the Psychosis Spectrum in the Early Course of Illness | 001 | 4 | NIH | 5/16/2022 | $48,231 |
| | 2022 | 2022 | MCLEAN HOSPITAL CORPORATION, THE | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01MH117012 | Neuroprogression across the Psychosis Spectrum in the Early Course of Illness | 000 | 4 | NIH | 2/2/2022 | $434,084 |
| | 2022 | 2022 | MCLEAN HOSPITAL CORPORATION, THE | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01AG060195 | Prevention of complement and immune-mediated Lewy body dementia | 000 | 5 | NIH | 4/19/2022 | $563,846 |
| | 2022 | 2022 | MCLEAN HOSPITAL CORPORATION, THE | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01MH117292 | Site 3/3, Understanding PTSD through Postmortem Targeted Brain Multiomics | 000 | 5 | NIH | 4/29/2022 | $594,777 |
| | 2022 | 2022 | MCLEAN HOSPITAL CORPORATION, THE | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | K23DK120517 | Understanding the Effects of Acute Stressors and Negative Emotion on Eating Behavior in Binge-Eating Disorder: The Role of Stressor-Induced Changes in Reward and Cognitive Control | 000 | 5 | NIH | 8/26/2022 | $194,217 |
| | 2022 | 2022 | MCLEAN HOSPITAL CORPORATION, THE | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | K23DK120517 | Understanding the Effects of Acute Stressors and Negative Emotion on Eating Behavior in Binge-Eating Disorder: The Role of Stressor-Induced Changes in Reward and Cognitive Control | 001 | 5 | NIH | 8/29/2022 | $193,335 |
| | 2022 | 2022 | MCLEAN HOSPITAL CORPORATION, THE | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01HD093680 | Behavioral and Neural Phenotypes of Primary Dysmenorrhea in Adolescents | 001 | 5 | NIH | 5/19/2022 | $0 |
| | 2022 | 2022 | MCLEAN HOSPITAL CORPORATION, THE | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01HD093680 | Behavioral and Neural Phenotypes of Primary Dysmenorrhea in Adolescents | 000 | 5 | NIH | 5/18/2022 | $592,169 |
| | 2022 | 2022 | MCLEAN HOSPITAL CORPORATION, THE | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01MH116033 | Emotion Regulation in Depression and the Aging Brain | 003 | 6 | NIH | 8/31/2022 | $486,858 |
| | 2022 | 2022 | MCLEAN HOSPITAL CORPORATION, THE | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | K23DA050808 | Improving Treatment Engagement in Individuals with Co-occurring Substance Use and Psychosis: A Telemedicine Family-Based Approach | 000 | 3 | NIH | 7/20/2022 | $189,232 |
| | 2022 | 2022 | MCLEAN HOSPITAL CORPORATION, THE | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R37MH068376 | Neuroimaging Studies of Reward Processing in Depression | 000 | 17 | NIH | 8/1/2022 | $785,591 |
| | 2022 | 2022 | MCLEAN HOSPITAL CORPORATION, THE | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | U01MH116925 | Robust Predictors of Mania and Psychosis | 000 | 4 | NIH | 5/19/2022 | $48,419 |
| | 2022 | 2022 | MCLEAN HOSPITAL CORPORATION, THE | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | T32MH125786 | Training to Enhance Alignment of Psychiatry and Neuroscience | 000 | 2 | NIH | 3/14/2022 | $403,743 |
| | 2022 | 2022 | MCLEAN HOSPITAL CORPORATION, THE | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | T32MH125786 | Training to Enhance Alignment of Psychiatry and Neuroscience | 001 | 2 | NIH | 4/19/2022 | $6,956 |
| | 2022 | 2022 | MCLEAN HOSPITAL CORPORATION, THE | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01MH111676 | Computational mechanisms of memory disruption in depression | 001 | 4 | NIH | 5/12/2022 | $41,000 |
| | 2022 | 2022 | MCLEAN HOSPITAL CORPORATION, THE | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01MH111676 | Computational mechanisms of memory disruption in depression | 000 | 4 | NIH | 10/27/2021 | $369,000 |
|
